RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2034

Description

RNA (Ribonucleic Acid) targeting small molecule therapeutics are a class of pharmaceutical compounds designed to specifically interact with RNA molecules within cells, modulating their function and activity to treat various diseases. RNA molecules play critical roles in gene expression, protein synthesis and cellular regulation and dysregulation of RNA function is implicated in numerous diseases, including cancer, genetic disorders, viral infections and neurodegenerative diseases.

The global RNA targeting small molecules therapeutics market was valued at $699.52 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 31.00%.

Growing Demand For Precision Medicine

Growing demand for precision medicine propelled the growth of the RNA targeting small molecules therapeutics market during the historic period. Personalized medicine refers to an innovative approach to medical treatment and healthcare that tailors medical decisions, practices, interventions and drug therapies to the individual patient. The growing interest in personalized medicine stems from its potential to tailor treatments to individual patients based on their unique genetic makeup, lifestyle factors and disease characteristics, leading to more effective and targeted therapeutic interventions. Personalized medicine in RNA-targeting small molecules can be designed with higher specificity, minimizing off-target effects and personalized to individual genetic variations. For instance, in 2022, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs). Out of the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, growing demand for precision medicine propelled the growth of the RNA targeting small molecules therapeutics market.

AI-Powered Deep Learning Revolutionizes RNA-Targeted Small Molecule Drug Discovery

Companies operating in the RNA targeting small molecule therapeutics market are focusing on using AI-driven deep-learning tool to accelerate drug discovery, optimize RNA-target interactions and identify novel therapeutic candidates with higher precision and efficiency. An AI-driven deep-learning tool is a software application or platform that uses artificial intelligence (AI) techniques, specifically deep learning, to perform tasks, analyze data and generate outputs that normally require human intelligence. For instance, in April 2025, Vanderbilt University, a private research university in Nashville, Tennessee, USA, developed, RNAmigos2, an AI-driven deep-learning tool that accelerates the discovery of RNA-targeting small-molecule drugs by 10,000 times compared to traditional methods. RNAmigos2 uses advanced RNA 3D modeling and synthetic data to rapidly and accurately screen large compound libraries, overcoming prior limitations in RNA drug discovery. This open-source tool aims to transform early-stage RNA drug discovery and enable the development of new therapies for diseases such as cancer and viral infections within a few years.

The global RNA targeting small molecule therapeutics market is highly concentrated, with large players operating in the market. The top 6 competitors in the market made up 68.49% of the total market in 2024.

RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global RNA targeting small molecules therapeutics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for RNA targeting small molecules therapeutics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The RNA targeting small molecules therapeutics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider RNA targeting small molecules therapeutics market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by offering, by therapeutic indication, by application and by end user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by offering, by therapeutic indication, by application and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size And Growth Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Recent Developments- Information on recent developments in the market covered in the report.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for RNA targeting small molecules therapeutics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Offering: mRNA (Messenger Ribonucleic Acid) Translation Modulators; RNA (Ribonucleic Acid) Splicing Modification; Direct RNA (Ribonucleic Acid) Targeting; Other Offerings
2) By Therapeutic Indication: Lung Fibrosis; Cancer; Neurodegenerative Diseases; Autoimmune; Inflammatory; Other Therapeutic Indications
3) By Application: Drug Discovery; Oncology Research; Disease Identification
4) By End User: Hospitals; Research Laboratories; Pharmaceutical and Biotechnology Companies; Other End-Users
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Teva Pharmaceuticals; Cipla Limited; Dr. Reddy's Laboratories; Zydus Lifesciences
Countries: Australia; China; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Austria; Belgium; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; RNA targeting small molecules therapeutics indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1790

1 Executive Summary

1.1 RNA Targeting Small Molecules Therapeutics - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 RNA Targeting Small Molecules Therapeutics Market Definition And Segmentations
6.4 Market Segmentation By Offering
- 6.4.1 mRNA (Messenger Ribonucleic Acid) Translation Modulators
- 6.4.2 RNA (Ribonucleic Acid) Splicing Modification
- 6.4.3 Direct RNA (Ribonucleic Acid) Targeting
- 6.4.4 Other Offerings
6.5 Market Segmentation By Therapeutic Indication
- 6.5.1 Lung Fibrosis
- 6.5.2 Cancer
- 6.5.3 Neurodegenerative Diseases
- 6.5.4 Autoimmune
- 6.5.5 Inflammatory
- 6.5.6 Other Therapeutic Indications
6.6 Market Segmentation By Application
- 6.6.1 Drug Discovery
- 6.6.2 Oncology Research
- 6.6.3 Disease Identification
6.7 Market Segmentation By End User
- 6.7.1 Hospitals
- 6.7.2 Research Laboratories
- 6.7.3 Pharmaceutical And Biotechnology Companies
- 6.7.4 Other End-Users

7 Major Market Trends

7.1 AI-Powered Deep Learning Revolutionizes RNA-Targeted Small Molecule Drug Discovery
7.2 Strategic Alliance To Develop RNA Splicing Modulators For Challenging Diseases
7.3 Strategic Collaboration And Partnership Fueling RNA Targeting Small Molecules Therapeutics
7.4 Focus on Startup-Driven AI Solutions for RNA-Targeted Therapeutics
7.5 Use Of Artificial Intelligence (AI) To Enhance Efficiency Of RNA Targeting Small Molecules

8 Global RNA Targeting Small Molecules Therapeutics Growth Analysis And Strategic Analysis Framework

8.1 Global RNA Targeting Small Molecules Therapeutics PESTEL Analysis
- 8.1.1 Political
- 8.1.2 Economic
- 8.1.3 Social
- 8.1.4 Technological
- 8.1.5 Environmental
- 8.1.6 Legal
8.2 Analysis Of End User (B2B)
- 8.2.1 Hospitals
- 8.2.2 Research Laboratories
- 8.2.3 Pharmaceutical And Biotechnology Companies
- 8.2.4 Other End-Users
8.3 Global RNA Targeting Small Molecules Therapeutics Market Growth Rate Analysis
8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
- 8.4.1 Market Drivers 2019 - 2024
- 8.4.2 Market Restraints 2019- 2024
8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
8.6 Forecast Growth Contributors/Factors
- 8.6.1 Quantitative Growth Contributors
- 8.6.2 Drivers
- 8.6.3 Restraints
8.7 Global RNA Targeting Small Molecules Therapeutics Total Addressable Market (TAM)

9 Global RNA Targeting Small Molecules Therapeutics Market Segmentation

9.1 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.2 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.3 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.4 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.5 Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of mRNA (Messenger Ribonucleic Acid) Translation Modulators, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.6 Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of RNA (Ribonucleic Acid) Splicing Modification, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.7 Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of Direct RNA (Ribonucleic Acid) Targeting, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.8 Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of Other Offerings, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 RNA Targeting Small Molecules Therapeutics Market, Regional and Country Analysis

10.1 Global RNA Targeting Small Molecules Therapeutics Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.2 Global RNA Targeting Small Molecules Therapeutics Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

11.1 Summary
11.2 Market Overview
- 11.2.1 Region Information
- 11.2.2 Market Information
- 11.2.3 Background Information
- 11.2.4 Government Initiatives
- 11.2.5 Regulations
- 11.2.6 Regulatory Bodies
- 11.2.7 Major Associations
- 11.2.8 Taxes Levied
- 11.2.9 Corporate Tax Structure
- 11.2.10 Investments
- 11.2.11 Major Companies
11.3 Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.6 Asia-Pacific RNA Targeting Small Molecules Therapeutics Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
- 11.9.1 Country Information
- 11.9.2 Market Information
- 11.9.3 Background Information
- 11.9.4 Government Initiatives
- 11.9.5 Regulations
- 11.9.6 Regulatory Bodies
- 11.9.7 Major Associations
- 11.9.8 Taxes Levied
- 11.9.9 Corporate Tax Structure
- 11.9.10 Investments
- 11.9.11 Major Companies
11.10 China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.11 China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.12 China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.13 India Market
11.14 India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.15 India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.16 India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
- 11.19.1 Country Information
- 11.19.2 Market Information
- 11.19.3 Background Information
- 11.19.4 Government Initiatives
- 11.19.5 Regulations
- 11.19.6 Regulatory Bodies
- 11.19.7 Major Associations
- 11.19.8 Taxes Levied
- 11.19.9 Corporate Tax Structure
- 11.19.10 Investments
- 11.19.11 Major Companies
11.20 Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.22 Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.23 South Korea Market
11.24 Summary
11.25 Market Overview
- 11.25.1 Country Information
- 11.25.2 Market Information
- 11.25.3 Background Information
- 11.25.4 Government Initiatives
- 11.25.5 Regulations
- 11.25.6 Regulatory Bodies
- 11.25.7 Major Associations
- 11.25.8 Taxes Levied
- 11.25.9 Corporate Tax Structure
- 11.25.10 Major Companies
11.26 South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.27 South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.28 South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.29 Australia Market
11.30 Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.31 Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.32 Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.33 Indonesia Market
11.34 Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.35 Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.36 Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

12.1 Summary
12.2 Market Overview
- 12.2.1 Region Information
- 12.2.2 Market Information
- 12.2.3 Background Information
- 12.2.4 Government Initiatives
- 12.2.5 Regulations
- 12.2.6 Regulatory Bodies
- 12.2.7 Major Associations
- 12.2.8 Taxes Levied
- 12.2.9 Corporate Tax Structure
- 12.2.10 Investments
- 12.2.11 Major Companies
12.3 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.6 UK Market
12.7 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.8 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.9 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.10 Germany Market
12.11 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.12 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.14 France Market
12.15 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.16 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.17 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.18 Italy Market
12.19 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.20 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.22 Spain Market
12.23 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.24 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

13.1 Summary
13.2 Market Overview
- 13.2.1 Region Information
- 13.2.2 Market Information
- 13.2.3 Background Information
- 13.2.4 Government Initiatives
- 13.2.5 Regulations
- 13.2.6 Regulatory Bodies
- 13.2.7 Major Associations
- 13.2.8 Taxes Levied
- 13.2.9 Corporate Tax Structure
- 13.2.10 Major companies
13.3 Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.6 Russia Market
13.7 Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.8 Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

14.1 Summary
14.2 Market Overview
- 14.2.1 Region Information
- 14.2.2 Market Information
- 14.2.3 Background Information
- 14.2.4 Government Initiatives
- 14.2.5 Regulations
- 14.2.6 Regulatory Bodies
- 14.2.7 Major Associations
- 14.2.8 Taxes Levied
- 14.2.9 Corporate Tax Structure
- 14.2.10 Investments
- 14.2.11 Major Companies
14.3 North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.6 North America RNA Targeting Small Molecules Therapeutics Market: Country Analysis
14.7 USA Market
14.8 Summary
14.9 Market Overview
- 14.9.1 Country Information
- 14.9.2 Market Information
- 14.9.3 Background Information
- 14.9.4 Government Initiatives
- 14.9.5 Regulations
- 14.9.6 Regulatory Bodies
- 14.9.7 Major Associations
- 14.9.8 Taxes Levied
- 14.9.9 Corporate Tax Structure
- 14.9.10 Investments
- 14.9.11 Major Companies
14.10 USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.11 Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.12 USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.13 USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.14 Canada Market
14.15 Summary
14.16 Market Overview
- 14.16.1 Country Information
- 14.16.2 Market Information
- 14.16.3 Background Information
- 14.16.4 Government Initiatives
- 14.16.5 Regulations
- 14.16.6 Regulatory Bodies
- 14.16.7 Major Associations
- 14.16.8 Taxes Levied
- 14.16.9 Corporate Tax Structure
- 14.16.10 Investments
- 14.16.11 Major Companies
14.17 Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.18 Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.19 Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

15.1 Summary
15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulations
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Major Companies
15.3 South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.4 South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.5 South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.6 Brazil Market
15.7 Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.8 Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

16.1 Summary
16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Investments
- 16.2.11 Major Companies
16.3 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

17.1 Summary
17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Major Companies
17.3 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.4 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.5 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

18.1 Company Profiles
18.2 F.Hoffmann-La Roche Ltd. (Genentech)
- 18.2.1 Company Overview
- 18.2.2 Products And Services
- 18.2.3 Business Strategy
- 18.2.4 Financial Overview
18.3 Teva Pharmaceuticals
- 18.3.1 Company Overview
- 18.3.2 Products And Services
- 18.3.3 Financial Overview
18.4 Cipla Limited
- 18.4.1 Company Overview
- 18.4.2 Products And Services
- 18.4.3 Financial Overview
18.5 Dr. Reddy's Laboratories Ltd
- 18.5.1 Company Overview
- 18.5.2 Products And Services
- 18.5.3 Financial Overview
18.6 Zydus Lifesciences (formerly Cadila Healthcare)
- 18.6.1 Company Overview
- 18.6.2 Products and Services
- 18.6.3 Financial Overview

19 Other Major And Innovative Companies

19.1 Apotex Inc.
- 19.1.1 Company Overview
- 19.1.2 Products and Services
19.2 Skyhawk Therapeutics
- 19.2.1 Company Overview
- 19.2.2 Products and Services
19.3 STORM Therapeutics
- 19.3.1 Company Overview
- 19.3.2 Products and Services
19.4 Arrakis Therapeutics Inc.
- 19.4.1 Company Overview
- 19.4.2 Products and Services
19.5 Anima Biotech Inc.
- 19.5.1 Company Overview
- 19.5.2 Products and Services
19.6 Ribometrix Inc.
- 19.6.1 Company Overview
- 19.6.2 Products and Services
19.7 Accent Therapeutics Inc.
- 19.7.1 Company Overview
- 19.7.2 Products and Services
19.8 Promega Corporation
- 19.8.1 Company Overview
- 19.8.2 Products and Services
19.9 Bayer AG
- 19.9.1 Company Overview
- 19.9.2 Products and Services
19.10 Arrowhead Pharmaceuticals Inc.
- 19.10.1 Company Overview
- 19.10.2 Products and Services
19.11 Ionis Pharmaceuticals Inc.
- 19.11.1 Company Overview
- 19.11.2 Products and Services
19.12 Alnylam Pharmaceuticals
- 19.12.1 Company Overview
- 19.12.2 Products and Services
19.13 Abivax SA
- 19.13.1 Company Overview
- 19.13.2 Products and Services
19.14 Remix Therapeutics
- 19.14.1 Company Overview
- 19.14.2 Products and Services
19.15 858 Therapeutics Inc.
- 19.15.1 Company Overview
- 19.15.2 Products and Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

22.1 Novartis Acquired Regulus Therapeutics Inc.

23 Recent Developments In The RNA Targeting Small Molecule Therapeutics Market

23.1 FDA Approves First Routine Prophylactic Therapy To Reduce Bleeding In Hemophilia Patients

24 Opportunities And Strategies

24.1 Global RNA Targeting Small Molecules Therapeutics Market In 2029 - Countries Offering Most New Opportunities
24.2 Global RNA Targeting Small Molecules Therapeutics Market In 2029 - Segments Offering Most New Opportunities
24.3 Global RNA Targeting Small Molecules Therapeutics Market In 2029 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies

25 RNA Targeting Small Molecules Therapeutics Market, Conclusions And Recommendations

25.1 Conclusions
25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People

26 Appendix

26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer